Skip to main content
BrainCited

Bacopa monnieri для Age-Related Cognitive Decline

B

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dbacopa\u002Dmonnieri\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Итог

A network meta-analysis found Bacopa outperformed Ginkgo on memory outcomes in elderly participants. Research suggests enhanced delayed word recall and improved Stroop Task performance with consistent supplementation.

Key Study Findings

Randomized Controlled Trial 6 weeks Double-blind
Effects of Bacopa monnieri herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in …
Dose: 120 mL twice daily for 45 days или: placebo Outcome: telomerase activity and telomere length Эффект: None None

Популяция: elderly participants with MoCA score >=24

Randomized Controlled Trial n=76 12 weeks Double-blind
Efficacy of Bacopa monnieri (Linn.) on Cognitive Function and Alterations in Blood Metabolites in Patients …
Dose: 300 mg/day standardized Bacopa monnieri extract или: placebo Outcome: change in composite z score of memory at … Эффект: None None

Популяция: patients with amnestic mild cognitive impairment, mean age 62.2 years, 88.3% men

Other
Differential Alterations in the Expression of AMPA Receptor and Its Trafficking Proteins in the Hippocampus …
Dose: 200 mg/kg body weight или: Rotenone-PD mice without BME Outcome: Recognition memory and AMPA receptor expression Эффект: None None

Популяция: Rotenone-induced Parkinson's disease mouse model

Systematic Review
Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review.
Dose: None или: None Outcome: Cholinesterase inhibition and cognitive improvement Эффект: None None

Популяция: In vivo animal models of AD

Other
A systems biology approach reveals dual neurotherapeutic mechanisms of Dioscorea bulbifera in Alzheimer's disease via …
Dose: None или: Donepezil, Estradiol Outcome: Neurotherapeutic activity via ESR1 and ACHE Эффект: None None

Популяция: In silico AD modeling (systems biology)

Systematic Review n=1861
The effect of plant active substances on cognitive function in healthy older adults: a systematic …
Dose: None или: Placebo or no intervention Outcome: Cognitive function (learning, memory, executive) Эффект: Raisin SUCRA 95.1%; tart cherry 89.5% for memory None

Популяция: Healthy older adults

Key Statistics

15

Исследования

1200

Участники

Positive

B

Оценка

Referenced Papers

Journal of alternative … 2021 13 цитирований
The Senior care … 2021 2 цитирований
Alzheimer's research & … 2021 1 цитирований
Pharmacological research 2018 67 цитирований
Evidence-based complementary and … 2015 82 цитирований
Neurochemical research 2012 85 цитирований
Alternative medicine review … 1999 112 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
300-600 mg/day standardized to 50% bacosides
memorysupport:
300 mg/day for minimum 8-12 weeks

Верхний предел: Not established; well-tolerated up to 600 mg/day in trials

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
120 mL twice daily for 45 days 6 weeks Neutral --
300 mg/day standardized Bacopa monnieri extract 12 weeks Neutral 76
200 mg/kg body weight -- Positive --
None -- Positive --
None -- Positive --
None -- Positive 1861
None -- Mixed --
None 12 weeks Positive --

Лучшее время приёма: With meals; effects require 8-12 weeks of consistent use

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Gastrointestinal discomfort (nausea, cramping, diarrhea)
  • Dry mouth
  • Fatigue in some individuals
  • Mild sedation at higher doses

Известные взаимодействия

  • Thyroid medications (may increase thyroid hormone levels)
  • Anticholinergic drugs (opposes cholinergic enhancement)
  • Sedative medications (additive CNS depression)
  • Calcium channel blockers (may enhance blood pressure lowering)

Допустимый верхний уровень потребления: Not established; well-tolerated up to 600 mg/day in trials

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Bacopa monnieri help with Age-Related Cognitive Decline?
Based on 15 studies with 1,200 participants, there is moderate evidence from clinical studies that Bacopa monnieri may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).
How much Bacopa monnieri should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 300-600 mg/day standardized to 50% bacosides. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacopa monnieri?
Reported side effects may include Gastrointestinal discomfort (nausea, cramping, diarrhea), Dry mouth, Fatigue in some individuals, Mild sedation at higher doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacopa monnieri and Age-Related Cognitive Decline?
We rate the evidence as Grade B (Good Evidence). This rating is based on 15 peer-reviewed studies with 1,200 total participants. The overall direction of effect is positive.

Related Evidence

Bacopa monnieri для других состояний

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.